InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: Timing101 post# 157617

Monday, 08/22/2022 7:15:02 PM

Monday, August 22, 2022 7:15:02 PM

Post# of 198725
Thanks! Spotted some tidbits:

Page 5:

Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer’s equity securities.

Check this box if there are no outstanding promissory, convertible notes or debt arrangements: x


No more convertible debt? This phrasing covers IOUs and debt that can be converted into classes other than Common.

I'll disclaimer this with: there should still be warrants which expire on November 16, 2023; and some parties hold already-converted shares in various classes.



Page 19:

The Company considers the forthcoming patent protection highly significant in view of the following facts:
[...]
To accelerate and fully execute the successful production of the multiple monoclonal antibodies, the subject of the Company's intellectual property (specifically the numerous monoclonal antibodies (mAbs) targeting both human and animal viruses), the Company continuously engages with numerous entities to accelerate its progress toward production, testing, and delivery of successful therapeutics. Entities with whom the Company is working include other Biotech Companies having:
[...]
As to each of these entities and those with whom the Company currently works on an ongoing basis, the Company has entered into NDAs (Nondisclosure Agreements) necessary to preserve and protect the Company plans and intellectual property being discussed and exchanged between the parties. These contractual restrictions are critical for the Company and its partners. Maintenance of strict confidentiality is essential to preserving intellectual property rights (patent rights) which are now being sought and will be sought in the future. Premature disclosure of information can bar the right to seek patent protection at a later date. The Company is not able to share specific details regarding arrangements regarding these NDAs.



So the NDAs are because of their international patent applications. This also implies we won't be getting any more news with specifics, until the day of the drop.

I edit too much! Refresh any of my recent posts to get silly little updates and clarifications.